Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women

Clinical trial NCT03201861 · RECRUITING

Trial details

NCT number: NCT03201861
Sponsor: RenJi Hospital
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Tubular Breast Cancer Mucinous Breast Cancer Invasive Duct Carcinoma of Breast

Start date: 2017-07-27
Primary completion: 2027-08-31
Enrollment: 762

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.